Recall events
/
Event 86663
Event summary
Timeline bucket October 27, 2020
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Zydus Pharmaceuticals (USA) Inc
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77
D-0074-2021
Recall number D-0074-2021
Initiated October 27, 2020
Classification Class II
Status Terminated
Quantity 6,840 units
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Failed Dissolution Specification
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Failed Dissolution Specification
Code information Lot # M005681, EXP 3/2022
Distribution pattern Distributed Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12162]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77
D-0075-2021
Recall number D-0075-2021
Initiated October 27, 2020
Classification Class II
Status Terminated
Quantity 7,908 units
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Failed Dissolution Specification
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Failed Dissolution Specification
Code information Lot # M005682, EXP 3/2022
Distribution pattern Distributed Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12247]
FDA event record
· Exact recall-number query on openFDA
